Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Ashour, Hossam M ^a   El Sharif, Amany ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Al Azhar University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MEZLOCILLIN; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CANCER PATIENT; CONTROLLED STUDY; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; LEUKEMIA; NONHUMAN; PATHOLOGICAL ANATOMY; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOLID TUMOR; URINARY TRACT INFECTION; DRUG EFFECT; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM NEGATIVE INFECTION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MORTALITY; NEOPLASM; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS;

EID: 62849089702     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-14     Document Type: Article

References (43)

1. Andrei A Zervos MJ The application of molecular techniques to the study of hospital infection Arch Pathol Lab Med 2006, 130:662-668. 16683884
2. Schabrun S Chipchase L Healthcare equipment as a source of nosocomial infection: A systematic review J Hosp Infect 2006, 63:239-245. 10.1016/ j.jhin.2005.10.013 16516340
3. Guinan JL McGuckin M Nowell PC Management of health-care-associated infections in the oncology patient Oncology (Williston Park) 2003, 17:415-420. 12661272
4. Ashour HM el-Sharif A Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients J Clin Oncol 2007, 25:5763-5769. 10.1200/JCO.2007.14.0947 18089873
5. Valles J Leon C Alvarez-Lerma F Nosocomial bacteremia in critically ill patients: A multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC) Clin Infect Dis 1997, 24:387-395. 9114190
6. Weinstein MP Towns ML Quartey SM Mirrett S Reimer LG Parmigiani G Reller LB The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults Clin Infect Dis 1997, 24:584-602. 9145732
7. Kucisec-Tepes N [Pseudomonas aeruginosa-a significant hospital pathogen and resistance to carbapenem] Acta Med Croatica 2004, 58:313-321. 15700688
8. Raad I Hachem R Hanna H Abi-Said D Bivins C Walsh G Thornby J Whimbey E Huaringa A Sukumaran A Treatment of nosocomial postoperative pneumonia in cancer patients: A prospective randomized study Ann Surg Oncol 2001, 8:179-186. 10.1007/s10434-001-0179-1 11258785
9. Mutnick AH Kirby JT Jones RN CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Ann Pharmacother 2003, 37:47-56. 10.1345/aph.1C292 12503932
10. Menashe G Borer A Yagupsky P Peled N Gilad J Fraser D Riesenberg K Schlaeffer F Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia Scand J Infect Dis 2001, 33:188-193. 10.1080/ 00365540151060806 11303808
11. Bilal NE Gedebou M Al-Ghamdi S Endemic nosocomial infections and misuse of antibiotics in a maternity hospital in Saudi Arabia Apmis 2002, 110:140-147. 10.1034/j.1600-0463.2002.110204.x 12064869
12. Hoheisel G Lange S Winkler J Rodloff AC Liebert UG Niederwieser D Schauer J Engelmann L [Nosocomial pneumonias in haematological malignancies in the medical intensive care unit] Pneumologie 2003, 57:73-77. 10.1055/s-2003-37152 12579460
13. Wisplinghoff H Seifert H Wenzel RP Edmond MB Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States Clin Infect Dis 2003, 36:1103-1110. 10.1086/374339 12715303
14. Jesus Hernandez-Navarrete M Arribas-Llorente JL Solano-Bernad VM Misiego-Peral A Rodriguez-Garcia J Fernandez-Garcia JL Martinez-German A [Quality improvement program of nosocomial infection in colorectal cancer surgery] Med Clin (Barc) 2005, 125:521-524. 10.1157/13080450 16266634
15. Vilar-Compte D Mohar A Sandoval S de la Rosa M Gordillo P Volkow P Surgical site infections at the National Cancer Institute in Mexico: A case-control study Am J Infect Control 2000, 28:14-20. 10.1016/ S0196-6553(00)90006-3 10679132
16. Espersen F Birgens HS Hertz JB Drivsholm A Current patterns of bacterial infection in myelomatosis Scand J Infect Dis 1984, 16:169-173. 6740248
17. Mortlock S Bacteraemia among patients attending a cancer hospital in Lahore, Pakistan Br J Biomed Sci 2000, 57:119-125. 10912285
18. Okazaki M Watanabe T Morita K Higurashi Y Araki K Shukuya N Baba S Watanabe N Egami T Furuya N et al.: Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks J Clin Microbiol 1999, 37:3809-3814. 85819 10565889
19. Chernukha M Alekseeva GV Shaginian IA Romanova Iu M Stepanova TV Batov AB Gintsburg AL [Virulent properties of hospital strains of bacteria of the Burkholderia cepacia complex, isolated in hospitals of Moscow] Zh Mikrobiol Epidemiol Immunobiol 2005:46-51. 16438375
20. Gorschluter M Hahn C Ziske C Mey U Schottker B Molitor E Becker S Marklein G Sauerbruch T Schmidt-Wolf IG Glasmacher A Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia Infection 2002, 30:22-25. 10.1007/ s15010-002-1178-2 11878289
21. Chong Y Lee K Present situation of antimicrobial resistance in Korea J Infect Chemother 2000, 6:189-195. 10.1007/s101560070001 11810564
22. Jones RN Resistance patterns among nosocomial pathogens: Trends over the past few years Chest 2001, 119:397S-404S. 10.1378/chest.119.2_suppl.397S 11171776
23. Oteo J Lazaro E de Abajo FJ Baquero F Campos J Antimicrobial-resistant invasive Escherichia coli, Spain Emerg Infect Dis 2005, 11:546-553. 15829192
24. Gold HS Moellering RC Jr Antimicrobial-drug resistance N Engl J Med 1996, 335:1445-1453. 10.1056/NEJM199611073351907 8875923
25. El Kholy A Baseem H Hall GS Procop GW Longworth DL Antimicrobial resistance in Cairo, Egypt 1999-2000: A survey of five hospitals J Antimicrob Chemother 2003, 51:625-630. 10.1093/jac/dkg101 12615864
26. Stein GE Pharmacokinetics and pharmacodynamics of newer fluoroquinolones Clin Infect Dis 1996, 23(Suppl 1):S19-24. 8953102
27. Rolston KV Kontoyiannis DP Yadegarynia D Raad II Nonfermentative gram-negative bacilli in cancer patients: Increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones Diagn Microbiol Infect Dis 2005, 51:215-218. 10.1016/ j.diagmicrobio.2004.11.002 15766609
28. Saied GM Microbial pattern and antimicrobial resistance, a surgeon's perspective: Retrospective study in surgical wards and seven intensive-care units in two university hospitals in Cairo, Egypt Dermatology 2006, 212(Suppl 1):8-14. 10.1159/000089193 16490969
29. Gunseren F Mamikoglu L Ozturk S Yucesoy M Biberoglu K Yulug N Doganay M Sumerkan B Kocagoz S Unal S et al.: A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey J Antimicrob Chemother 1999, 43:373-378. 10.1093/jac/43.3.373 10223593
30. Aksaray S Dokuzoguz B Guvener E Yucesoy M Yulug N Kocagoz S Unal S Cetin S Calangu S Gunaydin M et al.: Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in turkey J Antimicrob Chemother 2000, 46:649. 11020272
31. Cavallo JD Plesiat P Couetdic G Leblanc F Fabre R Mechanisms of beta-lactam resistance in Pseudomonas aeruginosa: Prevalence of OprM-overproducing strains in a French multicentre study (1997) J Antimicrob Chemother 2002, 50:1039-1043. 10.1093/jac/dkf186 12461030
32. Gulay Z Atay T Amyes SG Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital J Chemother 2001, 13:546-554. 11760220
33. Spanu T Luzzaro F Perilli M Amicosante G Toniolo A Fadda G Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to beta-lactams and other antimicrobial drugs Antimicrob Agents Chemother 2002, 46:196-202. 126983 11751134 10.1128/AAC.46.1.196-202.2002
34. Guducuoglu H Durmaz R Yaman G Cizmeci Z Berktas M Durmaz B Spread of a single clone Acinetobacter baumannii strain in an intensive care unit of a teaching hospital in Turkey New Microbiol 2005, 28:337-343. 16386018
35. Pfaller MA Jones RN Doern GV Sader HS Messer SA Houston A Coffman S Hollis RJ Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998 Antimicrob Agents Chemother 2000, 44:747-751. 89757 10681349 10.1128/AAC.44.3.747-751.2000
36. Gales AC Jones RN Forward KR Linares J Sader HS Verhoef J Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) Clin Infect Dis 2001, 32(Suppl 2):S104-113. 10.1086/320183 11320451
37. Honderlick P Saheb F Cahen P Emergence of multidrug-resistant Enterobacter cloacae: Nosocomial outbreak or change of microbial ecology? Pathol Biol (Paris) 1999, 47:437-439. 10418014
38. Yu WL Cheng HS Lin HC Peng CT Tsai CH Outbreak investigation of nosocomial enterobacter cloacae bacteraemia in a neonatal intensive care unit Scand J Infect Dis 2000, 32:293-298. 10.1080/00365540050165947 10879601
39. Jean SS Teng LJ Hsueh PR Ho SW Luh KT Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital J Antimicrob Chemother 2002, 49:69-76. 10.1093/jac/49.1.69 11751769
40. Neth O Hann I Turner MW Klein NJ Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study Lancet 2001, 358:614-618. 10.1016/S0140-6736(01)05776-2 11530147
41. Wisplinghoff H Cornely OA Moser S Bethe U Stutzer H Salzberger B Fatkenheuer G Seifert H Outcomes of nosocomial bloodstream infections in adult neutropenic patients: A prospective cohort and matched case-control study Infect Control Hosp Epidemiol 2003, 24:905-911. 10.1086/502158 14700405
42. Koprnova J Svetlansky I Babel'a R Bilikova E Hanzen J Zuscakova IJ Milovsky V Masar O Kovacicova G Gogova M et al.: Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia Scand J Infect Dis 2001, 33:891-895. 10.1080/00365540110076688 11868760
43. Pfaller MA Jones RN Doern GV Fluit AC Verhoef J Sader HS Messer SA Houston A Coffman S Hollis RJ International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe) Diagn Microbiol Infect Dis 1999, 35:19-25. 10.1016/ S0732-8893(99)00046-2 10529877